Prima Retinal Prosthesis for Advanced Macular Degeneration
The Prima retinal prosthesis, developed by Stanford Medicine, has shown promising results in restoring vision to individuals with advanced macular degeneration.
According to a study published in the New England Journal of Medicine, 27 out of 32 participants regained the ability to read a year after receiving the device.
- With digital enhancements, some participants achieved acuity equivalent to 20/42 vision.
- The device enables features such as zoom and higher contrast.
The Prima device is a "next-generation miniaturized sub-retinal implant."
The technology was initially developed at the lab of Daniel Palanker and underwent early clinical development by Pixium Vision, before being acquired by Science Corporation in 2024.
Author's summary: Prima prosthesis restores vision in macular degeneration patients.
More News
- Battlefield 6 REDSEC battle royale to officially launch soon
- Pressing need for ethical and regulatory oversight of therapeutic voice AI, SFU expert urges
- The new age of pediatric medication awareness - Express Healthcare
- Why Hiring a Fishers Personal Injury Lawyer Is Key After a Car Accident, Slip, or Dog Bite | NorthPennNow
- Why Experienced Lawyers Matter in a Personal Injury Case | NorthPennNow
- 2 US Navy aircraft crash in South China Sea
- Partnerships to innovate access to medicines - BusinessWorld Online
- Budget jitters see construction forecasts plummet
- Battlefield 6's Battle Royale Mode Is Called REDSEC, Is Free-To-Play, And Launches Tomorrow
- UO’s celebration of Indigenous lives - Daily Emerald